Drreddys Laboratories | RDY - Attività Correnti





Attività Correnti Cambiamento Data
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Canopy Growth CAD 529.47M 4.8M 2026-03
Cipla INR 241.47B 7.71B 2026-03
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Drreddys Laboratories INR 301.98B 298.66B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Novartis USD 26.61B 3.85B 2026-03
Pacira USD 514.96M 33.01M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 431.48M 1.94M 2026-03
Richter Gedeon HUF 841.24B 69.09B 2026-03
Sun Pharmaceuticals INR 638.6B 37.24B 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03